The U.S. Food and Drug Administration is moving toward allowing compounding pharmacies to produce more than a dozen injectable peptides that were banned because of potentially significant safety risks, the New York AOD 9604: The Fat Loss Peptide You'll Soon Be Able to Get Again Meto blog Watson responsible for AOD 9604 use, says WADA boss Fahey AOD 9604 (Lipotropin) Las Vegas Sky Health Wellness Clinic The FDA has repeatedly flagged AOD 9604 as a compound of concern. It was placed on the Category 2 list in 2023 bulk drug substances in compounding that may present significant What is AOD 9604 and How Does It Work?AOD 9604 is a modified fragment of human growth hormone (HGH) thats been developed specifically for its fat burning propertieswithout the muscle building